Detalhe da pesquisa
1.
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment.
Cell
; 187(7): 1617-1635, 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38552610
2.
A neutrophil response linked to tumor control in immunotherapy.
Cell
; 186(7): 1448-1464.e20, 2023 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37001504
3.
Strength in numbers: predicting response to checkpoint inhibitors from large clinical datasets.
Cell
; 184(3): 571-573, 2021 02 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33508231
4.
First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study.
Lancet
; 402(10400): 451-463, 2023 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37423228
5.
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial.
Lancet
; 401(10378): 733-746, 2023 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36764316
6.
[Oncology: what's new in 2023]. / Oncologie: ce qui a changé en 2023.
Rev Med Suisse
; 20(856-7): 80-87, 2024 Jan 17.
Artigo
em Francês
| MEDLINE | ID: mdl-38231107
7.
The Utility of ctDNA in Lung Cancer Clinical Research and Practice: A Systematic Review and Meta-Analysis of Clinical Studies.
Cancer Invest
; 41(6): 571-592, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37272675
8.
Population pharmacokinetic modelling of tremelimumab in patients with advanced solid tumours and the impact of disease status on time-varying clearance.
Br J Clin Pharmacol
; 89(5): 1601-1616, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36454221
9.
[Lung cancer screening : towards the implementation of a pilot project in Switzerland]. / Dépistage du cancer pulmonaire : vers l'implémentation d'un projet pilote en Suisse.
Rev Med Suisse
; 19(850): 2165-2171, 2023 Nov 15.
Artigo
em Francês
| MEDLINE | ID: mdl-37966148
10.
[Oncology: what's new in 2022]. / Oncologie : ce qui a changé en 2022.
Rev Med Suisse
; 19(N° 809-10): 52-57, 2023 Jan 18.
Artigo
em Francês
| MEDLINE | ID: mdl-36660838
11.
High-dose alectinib for RET fusion-positive non-small cell lung cancer in the Blood First Assay Screening Trial.
Contemp Oncol (Pozn)
; 27(4): 217-223, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38405208
12.
Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB-IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial.
Lancet Oncol
; 23(10): 1274-1286, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36108662
13.
First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial.
Lancet
; 397(10272): 375-386, 2021 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33485464
14.
Adjuvant Alectinib in ALK-Rearranged NSCLC - Here and Now.
N Engl J Med
; 390(14): 1325-1327, 2024 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38598800
15.
Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer.
N Engl J Med
; 381(21): 2020-2031, 2019 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31562796
16.
Deciphering the immunosuppressive tumor microenvironment in ALK- and EGFR-positive lung adenocarcinoma.
Cancer Immunol Immunother
; 71(2): 251-265, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34125345
17.
Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape project.
Mod Pathol
; 35(12): 1888-1899, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36115922
18.
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 2nd - 4th, 2021, Italy).
J Transl Med
; 20(1): 391, 2022 09 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36058945
19.
Patients' experiences with cancer care in Switzerland: Results of a multicentre cross-sectional survey.
Eur J Cancer Care (Engl)
; 31(6): e13705, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36130722
20.
[Targeted therapies and non-small cell carcinomas : novelties]. / Thérapies ciblées et carcinomes non à petites cellules : nouveautés.
Rev Med Suisse
; 18(782): 970-975, 2022 May 18.
Artigo
em Francês
| MEDLINE | ID: mdl-35583275